{
    "nctId": "NCT01183832",
    "briefTitle": "Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects",
    "officialTitle": "Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 490,
    "primaryOutcomeMeasure": "radiation side effects",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Post-menopausal woman without superior age limit\n* No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy\n* The patients including in another clinical trial can be include in this observatory",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}